Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 8, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 31
- 0 vs. Q3 2022
- Portfolio value
- $437.4M
- +$49.4M (+12.7%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 596,036 | $51.2M | 11.7% | −287,070−32.5% | Reduced | History |
| INCYIncyte Corp | COM | 411,487 | $33.1M | 7.6% | −7,307−1.7% | Reduced | History |
| CAHCardinal Health Inc | Stock | 353,872 | $27.2M | 6.2% | −4,828−1.3% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 377,669 | $27.2M | 6.2% | +24,042+6.8% | Added | History |
| ELVElevance Health, Inc. | Stock | 47,777 | $24.5M | 5.6% | +1,745+3.8% | Added | History |
| MRKMerck & Co., Inc. | Stock | 199,300 | $22.1M | 5.1% | −53,859−21.3% | Reduced | History |
| MDTMedtronic plc | Stock | 277,435 | $21.6M | 4.9% | +7,478+2.8% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 154,116 | $19.6M | 4.5% | −11,964−7.2% | Reduced | History |
| BIIBBiogen Inc. | COM | 70,039 | $19.4M | 4.4% | −40,191−36.5% | Reduced | History |
| LHLabcorp Holdings Inc. | COM NEW | 74,496 | $17.5M | 4.0% | +74,496 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 155,009 | $16.0M | 3.7% | +45,405+41.4% | Added | History |
| CNCCentene Corp | Stock | 184,901 | $15.2M | 3.5% | −16,654−8.3% | Reduced | History |
| SGENSeagen Inc. | COM | 106,207 | $13.6M | 3.1% | +21,477+25.3% | Added | History |
| BSXBoston Scientific Corp | Stock | 294,784 | $13.6M | 3.1% | −92,400−23.9% | Reduced | History |
| BRKRBruker Corp | COM | 191,982 | $13.1M | 3.0% | −45,976−19.3% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 174,252 | $13.0M | 3.0% | +174,252 | New | History |
| QGENQiagen N.V. | SHS NEW | 233,473 | $11.6M | 2.7% | +29,399+14.4% | Added | History |
| BAXBaxter International Inc | Stock | 221,088 | $11.3M | 2.6% | +52,060+30.8% | Added | History |
| ILMNIllumina, Inc. | COM | 47,500 | $9.60M | 2.2% | +47,500 | New | History |
| THCTenet Healthcare Corp | COM NEW | 195,954 | $9.56M | 2.2% | +195,954 | New | History |
| CICigna Group | Stock | 22,252 | $7.37M | 1.7% | −28,265−56.0% | Reduced | History |
| NUVANuvasive Inc | COM | 173,842 | $7.17M | 1.6% | −74,807−30.1% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 15,988 | $6.72M | 1.5% | +4,000+33.4% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 141,373 | $5.34M | 1.2% | −22,850−13.9% | Reduced | History |
| CVSCVS Health Corp | Stock | 43,443 | $4.05M | 0.9% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 23,738 | $3.57M | 0.8% | +23,738 | New | History |
| PTCTPTC Therapeutics, Inc. | COM | 86,692 | $3.31M | 0.8% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 185,835 | $2.96M | 0.7% | +185,835 | New | History |
| CTLTCatalent, Inc. | COM | 55,000 | $2.48M | 0.6% | +55,000 | New | History |
| VIRVir Biotechnology, Inc. | COM | 89,808 | $2.27M | 0.5% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 45,520 | $2.11M | 0.5% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (7)
Positions held at the end of Q3 2022 that are gone from this filing.
| Security | Class | Shares in Q3 2022 | Value in Q3 2022 | % of portfolio in Q3 2022 | History |
|---|---|---|---|---|---|
| SAGESage Therapeutics, Inc. | COM | 115,696 | $4.53M | 1.2% | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 68,612 | $3.19M | 0.8% | History |
| UHSUniversal Health Services Inc | CL B | 27,077 | $2.39M | 0.6% | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,346,904 | $1.59M | 0.4% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 6,921 | $1.39M | 0.4% | History |
| NVAXNovavax Inc | COM NEW | 56,735 | $1.03M | 0.3% | History |
| EMBCEmbecta Corp. | Stock | 5,246 | $151.0K | <0.1% | History |